UBS Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.8M | Buy |
4,291,711
+3,978,358
| +1,270% | +$12.6M | ﹤0.01% | 3164 |
|
|
2025
Q4 | $1.16M | Sell |
313,353
-932,957
| -75% | -$3.01M | ﹤0.01% | 5442 |
|
|
2025
Q3 | $3.3M | Sell |
1,246,310
-290,902
| -19% | -$563K | ﹤0.01% | 4463 |
|
|
2025
Q2 | $1.51M | Buy |
1,537,212
+867,294
| +129% | +$868K | ﹤0.01% | 5091 |
|
|
2025
Q1 | $965K | Sell |
669,918
-207,024
| -24% | -$381K | ﹤0.01% | 5307 |
|
|
2024
Q4 | $1.93M | Buy |
876,942
+786,649
| +871% | +$1.84M | ﹤0.01% | 4755 |
|
|
2024
Q3 | $149K | Buy |
90,293
+22,117
| +32% | +$44.7K | ﹤0.01% | 6074 |
|
|
2024
Q2 | $151K | Buy |
68,176
+46,776
| +219% | +$110K | ﹤0.01% | 5861 |
|
|
2024
Q1 | $57.4K | Buy |
21,400
+240
| +1% | +$583 | ﹤0.01% | 6450 |
|
|
2023
Q4 | $63.3K | Sell |
21,160
-10,000
| -32% | -$13K | ﹤0.01% | 6420 |
|
|
2023
Q3 | $30.5K | Sell |
31,160
-24,042
| -44% | -$34.8K | ﹤0.01% | 6579 |
|
|
2023
Q2 | $76.7K | Sell |
55,202
-8,389
| -13% | -$11.7K | ﹤0.01% | 6204 |
|
|
2023
Q1 | $101K | Buy |
63,591
+40,130
| +171% | +$207K | ﹤0.01% | 5898 |
|
|
2022
Q4 | $146K | Buy |
23,461
+9,377
| +67% | +$67.1K | ﹤0.01% | 5750 |
|
|
2022
Q3 | $95K | Sell |
14,084
-2,370
| -14% | -$16.3K | ﹤0.01% | 5752 |
|
|
2022
Q2 | $104K | Buy |
16,454
+2,610
| +19% | +$14.8K | ﹤0.01% | 5403 |
|
|
2022
Q1 | $64K | Sell |
13,844
-50,898
| -79% | -$218K | ﹤0.01% | 6248 |
|
|
2021
Q4 | $323K | Buy |
64,742
+30,226
| +88% | +$242K | ﹤0.01% | 5315 |
|
|
2021
Q3 | $416K | Sell |
34,516
-18,624
| -35% | -$271K | ﹤0.01% | 4852 |
|
|
2021
Q2 | $1.12M | Sell |
53,140
-13,435
| -20% | -$324K | ﹤0.01% | 4083 |
|
|
2021
Q1 | $1.87M | Buy |
66,575
+52,296
| +366% | +$1.54M | ﹤0.01% | 3631 |
|
|
2020
Q4 | $371K | Sell |
14,279
-9,279
| -39% | -$278K | ﹤0.01% | 4833 |
|
|
2020
Q3 | $875K | Sell |
23,558
-32,690
| -58% | -$1.29M | ﹤0.01% | 3737 |
|
|
2020
Q2 | $2.89M | Sell |
56,248
-30,175
| -35% | -$1.26M | ﹤0.01% | 2535 |
|
|
2020
Q1 | $2.73M | Buy |
86,423
+21,458
| +33% | +$1.13M | ﹤0.01% | 2462 |
|
|
2019
Q4 | $3.87M | Buy |
64,965
+53,670
| +475% | +$2.41M | ﹤0.01% | 2856 |
|
|
2019
Q3 | $414K | Sell |
11,295
-3,452
| -23% | -$137K | ﹤0.01% | 4714 |
|
|
2019
Q2 | $686K | Sell |
14,747
-10,074
| -41% | -$473K | ﹤0.01% | 4052 |
|
|
2019
Q1 | $997K | Sell |
24,821
-160,621
| -87% | -$7.21M | ﹤0.01% | 3595 |
|
|
2018
Q4 | $8.53M | Buy |
185,442
+114,538
| +162% | +$5.52M | ﹤0.01% | 1698 |
|
|
2018
Q3 | $3.15M | Buy |
70,904
+30,941
| +77% | +$1.42M | ﹤0.01% | 2780 |
|
|
2018
Q2 | $1.57M | Sell |
39,963
-70,919
| -64% | -$3.58M | ﹤0.01% | 3383 |
|
|
2018
Q1 | $8.02M | Buy |
110,882
+26,975
| +32% | +$1.98M | ﹤0.01% | 1889 |
|
|
2017
Q4 | $5.52M | Sell |
83,907
-20,284
| -19% | -$1.09M | ﹤0.01% | 2261 |
|
|
2017
Q3 | $5.22M | Sell |
104,191
-47,870
| -31% | -$2.31M | ﹤0.01% | 2155 |
|
|
2017
Q2 | $7.04M | Buy |
152,061
+50,930
| +50% | +$1.87M | ﹤0.01% | 1835 |
|
|
2017
Q1 | $3.57M | Buy |
101,131
+52,712
| +109% | +$1.21M | ﹤0.01% | 2394 |
|
|
2016
Q4 | $606K | Sell |
48,419
-954
| -2% | -$11.4K | ﹤0.01% | 3964 |
|
|
2016
Q3 | $684K | Buy |
49,373
+35,292
| +251% | +$400K | ﹤0.01% | 3688 |
|
|
2016
Q2 | $140K | Buy |
14,081
+2,834
| +25% | +$47K | ﹤0.01% | 4794 |
|
|
2016
Q1 | $190K | Sell |
11,247
-131,765
| -92% | -$2.12M | ﹤0.01% | 4522 |
|
|
2015
Q4 | $3.18M | Buy |
143,012
+80,215
| +128% | +$2.02M | ﹤0.01% | 2370 |
|
|
2015
Q3 | $1.48M | Buy |
62,797
+49,752
| +381% | +$3.12M | ﹤0.01% | 3009 |
|
|
2015
Q2 | $1.07M | Buy |
13,045
+12,422
| +1,994% | +$1.22M | ﹤0.01% | 3511 |
|
|
2015
Q1 | $58K | Sell |
623
-4,034
| -87% | -$260K | ﹤0.01% | 5904 |
|
|
2014
Q4 | $189K | Buy |
+4,657
| New | +$143K | ﹤0.01% | 5100 |
|
Other funds holding ESPR
WA
TSC
O
VCM
